Phosphonoacetic acid at concentrations above 200 ,g/ml inhibited the replication of frog virus 3 in BHK cells. The inhibition of viral DNA replication observed in these cells was reversible and correlated with the inhibition of the virus-induced DNA polymerase activity in an in vitro assay. The synthesis of frog virus 3-induced late or -y polypeptides was also inhibited by phosphonoacetic acid, although the early (a and ,8) polypeptides were unaffected.
Phosphonoacetic acid at concentrations above 200 ,g/ml inhibited the replication of frog virus 3 in BHK cells. The inhibition of viral DNA replication observed in these cells was reversible and correlated with the inhibition of the virus-induced DNA polymerase activity in an in vitro assay. The synthesis of frog virus 3-induced late or -y polypeptides was also inhibited by phosphonoacetic acid, although the early (a and ,8) polypeptides were unaffected.
Phosphonoacetic acid (PAA) is a potent inhibitor of the replication of a number of herpesviruses in tissue culture (9, 19, 20) . It affects a virus-induced DNA polymerase (9) , and the drug significantly reduces the severity of herpesvirus infections in model animal systems (4, 12, 15, 19, 20) . This compound has little effect on other animal DNA viruses, with the exception of vaccinia virus (2, 9) .
Frog virus 3 (FV3) is a large, icosahedral deoxyribovirus which apparently replicates in the cytoplasm of infected cells (7, 11) but has a requirement for the cell nucleus (5, 6) . A virusinduced DNA polymerase activity has been described in FV3-infected cells (14, 17) . Certain features ofthe replication of FV3 are reminiscent of herpesvirus replication and McAuslan and Armentrout (16) have suggested that FV3 represents a "missing link" between herpesviruses and poxviruses. We therefore thought it pertinent to study the effect of PAA on FV3 replication, especially since Honess and Watson (9) have suggested that PAA sensitivity may be a herpesvirus group defining characteristic. In this paper we demonstrate that PAA inhibits FV3 replication in a reversible manner by blocking FV3 DNA synthesis at the level of the induced DNA polymerase and report on the effect of PAA on the synthesis of polypeptides in FV3-infected cells.
The disodium salt of PAA was a gift from Abbott Laboratories Inc., Chicago, Ill. The following radioisotopes were purchased from the Radiochemical Centre, Amersham, England: [methyl-3H]thymidine (20 The effect of PAA on FV3 DNA replication was tested by using petri dishes containing 2 x 105 BHK cells which were infected with 10 PFU of virus per cell, as described above. After adsorption, the cultures were incubated in medium without PAA or with 300 ,ug of PAA per ml present. To determine the reversibility of PAA, some cultures were washed five times with minimal essential medium, and incubation was continued in the absence of PAA. At various times after infection, the medium was replaced by minimal essential medium containing 30,uCi of [3H]thymidine per ml. Monolayers incubated with PAA were also labeled in the presence of the drug. After a 1-h pulse, the label was removed, the monolayers were washed with icecold phosphate-buffered saline, and the cells were scraped into cold 5% trichloroacetic acid. Trichloroacetic acid-precipitable material was collected by filtration, washed with trichloroacetic acid and ethanol, and counted in a liquid scintillation analyzer. Analysis of DNA in infected cells with CsCl gradients shows that over 95% of the cellular synthesis is viral 3 h after infection (14; Elliott and Kelly, unpublished data).
DNA polymerase was assayed in cells extracts as follows. Mock-infected or FV3-infected (multiplicity of infection, 1 PFU/cell) BHK cells were harvested 24 h after infection by washing in cold phosphate-buffered saline scraping into phosphate-buffered saline, and pelleting by centrifugation. The pellet (approximately 5 x 107 cells) was resuspended in 2 ml of sterile distilled water and sonicated for 10 min in a sonicating water bath. Samples of these lysates were stored at -20°C until use. The DNA polymerase reaction mixture contained, in a volume of 280 pl, 17 The reaction mixture was incubated for 1 h at 28°C and terminated by chilling and adding 10 ml of 205 mM perchloric acid containing 1 mM sodium pyrophosphate, 0.41 mM thymidine, and 100 Mg of heat-denatured calf thymus DNA carrier. After incubation at 4°C overnight, the precipitate was collected by filtration and washed with perchloric acid and ethanol, and the radioactivity was counted.
Radiolabeling and analysis of polypeptides synthesized in infected cells were performed as described in an acompanying paper (3) . To examine the effect of PAA on FV3 DNA replication, we studied the uptake of [3H]thymidine by FV3-infected cells in the presence of an excess (300 ,g/ml) of the drug. Figure 1B shows that in untreated FV3-infected monolayers there was a marked increase in incorporation of label into trichloroacetic acid-precipi- i-c corresponded to the time taken for viral DNA synthesis to occur in untreated cultures. Figure 1C shows the effect of PAA concentration on DNA polymerase activity in FV3-infected and mock-infected cells. A concentration of 20 jig of PAA per ml reduced the activity of the FV3-induced enzyme by 50%; about 80% inhibition of the enzyme was observed at 100 jig of PAA per ml. In contrast, the activity of the DNA polymerase in uninfected BHK cells was not affected by concentrations of PAA up to 100 ,g/ml.
Three phases of polypeptide synthesis have been observed in FV3-infected cells; these phases are designated a, ,B, and y (4). The synthesis of -y polypeptides ("late" polypeptides) is dependent on the replication of viral DNA (3), and experiments were designed to examine the effects of PAA on FV3-induced polypeptides.
In the experiment shown in Fig. 2 FV3-infected cells maintained in the presence or absence of 300 Mug of PAA per ml were pulse-labeled at various times after infection. There was a marked overall decrease in the incorporation of tion (by which time y polypeptide synthesis was clearly observed in untreated infected cells) no y polypeptides were seen in the PAA-treated cells. However, after 24 h of incubation in PAA, some -y polypeptides were synthesized (e.g., infected cell-specific polypeptide 55), but the synthesis of others (e.g., infected cell-specific polypeptide 23) was still inhibited. The synthesis of cellular polypeptides in mock-infected cells was not affected by PAA.
In this communication we have demonstrated that PAA inhibits the replication of FV3 under conditions where uninfected cells remain unaffected. The drug inhibited the replication of FV3 DNA (as judged by radioactive thymidine uptake), but its effects could be reversed by extensive washing. Consequently, the synthesis of -y or late polypeptides, which is dependent on viral DNA replication, was inhibited by PAA, but the synthesis of prereplicative or a and ,B polypeptides was unaffected. These data suggested that an early virus function was inhibited, and this conclusion was supported by the in vitro inhibition of the virus-induced DNA polymerase (which by definition must be an early polypeptide). Thus, our findings are consistent with the observation that the inhibition of FV3 is via the induced DNA polymerase (9) .
The concentrations of PAA required to inhibit FV3 replication are higher than those reported for the herpesviruses, and this suggests either an inherent reduced sensitivity to the drug or a high proportion of PAA-resistant mutants; this could prove useful in genetic studies with FV3, as PAA-resistant mutants can be isolated with relative ease among herpesviruses (9, 12) .
While this manuscript was in preparation, Moreno et al. (18) reported the inhibition by PAA of another icosahedral cytoplasmic deoxyribovirus, African swine fever virus (9) ; this suggested that sensitivity to PAA may be a characteristic of the icosahedral cytoplasmic deoxyribovirus group.
Our preliminary observations indicate that the replication of another icosahedral cytoplasmic deoxyribovirus, iridescent virus type 22 (1), is not affected by PAA; however, the possibility that this was due to poor uptake of the drug by the insect cell line used for the experiment cannot be ruled out.
We thank R. W. Honess for providing PAA for our preliminary investigation and Abbott Laboratories for the gift of PAA for this study. 
